Announcements Trials
Browse Landscape

Status

Recruiting 6Completed 3Terminated 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 19Observational 6

Sponsor

Cancer Type

Genitourinary 6

Conditions

Neoplasms 518Breast Neoplasms 461Lung Neoplasms 256Prostatic Neoplasms 235Colorectal Neoplasms 218Carcinoma, Non-Small-Cell Lung 188Pancreatic Neoplasms 157Stomach Neoplasms 140Carcinoma, Hepatocellular 136Ovarian Neoplasms 120Multiple Myeloma 98Melanoma 95Head and Neck Neoplasms 95Esophageal Neoplasms 94Urinary Bladder Neoplasms 87Disease 87Lymphoma 79Uterine Cervical Neoplasms 78Hematologic Neoplasms 77Liver Neoplasms 76Brain Neoplasms 76Endometrial Neoplasms 73Neoplasm Metastasis 65Leukemia, Myeloid, Acute 65Colonic Neoplasms 61Rectal Neoplasms 60Precursor Cell Lymphoblastic Leukemia-Lymphoma 57Leukemia 54Sarcoma 53Glioma 53

Interventions

Pluvicto 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Observational × Metastatic Castration-resistant Prostate Cancer × Clear all
NCT06031805 2026-04-27

PROWESs

AstraZeneca

Recruiting
300 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT06242509 2026-04-27

AkkPRO

Assistance Publique - Hôpitaux de Paris

Recruiting
52 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT06514521 2025-12-30

Post Marketing Study on Pluvicto in Korea

Novartis

Recruiting
278 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT06380738 2025-12-26

PROceed

AstraZeneca

Recruiting
250 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT05116579 2024-09-05

Circulating Tumor DNA (ctDNA) Monitoring in the Assessment and Prediction of the Efficacy of PARP Inhibitors (PARPi)

Sun Yat-sen University

Recruiting
30 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT06529549 2024-07-31

Efficacy and Safety of Organoid-Based Drug Sensitivity Screening to Guide the Treatment of mCRPC Patients Progressed After First-line Treatment

Sun Yat-sen University

Recruiting
30 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡